secwatch.observer — SEC 8-K summary
======================================

Issuer:     Corvex, Inc. (MOVE)
CIK:        0001734750
Form:       8-K
Filed at:   2023-05-15T23:59:59+00:00
Accession:  0001213900-23-039342
Event type: earnings
Sentiment:  neutral
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Movano Health Q1 2023 net loss $7.1M; Evie Ring launch planned September at $269
--------------------------------------------------------------------------------

- Net loss of $7.1M ($0.19 per share) in Q1 2023 vs $6.9M loss in Q1 2022; no revenue generated.
- Evie Ring to launch September 2023 at $269 with no subscription; 510(k) submission for heart rate/SpO2 expected June 2023.
- Over 80,000 sign-ups and nearly 500,000 website visits since Evie Ring announcement at CES in January 2023.
- Completed first beta programs with four partners; second beta round by early July includes global athletic apparel company.
- Completed blood pressure clinical trial with 50+ subjects using proprietary RF single-chip solution; glucose trial planned.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1734750/000121390023039342/0001213900-23-039342-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1734750/000121390023039342/ea178538-8k_movano.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-039342

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer